ArticleBMC nephrology2026
National survey of blood pressure management practices in peritoneal dialysis.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundContemporary practices for blood pressure (BP) management in peritoneal dialysis (PD) remain poorly characterized despite cardiovascular disease and hypertension being highly prevalent in patients on PD.
methodsWe conducted a national survey of nephrologists in the United States with publicly available email addresses affiliated with the 150 ACGME-accredited adult nephrology training programs. Email invitations were sent to 1786 nephrologists between January and February 2026. 100 nephrologists actively caring for patients on PD consented and completed the survey.
resultsWe found wide variation in BP management practices amongst nephrologists. 68% nephrologists use both home and clinic BP measurements to guide treatment decisions, while 32% rely primarily on home BP. Involvement in patient education regarding BP measurement technique was inconsistent. About 25% nephrologists had minimal or no involvement, and 48% had partial involvement with staff-led education. Knowledge about the patient's home BP device or cuff placement was also limited. The target systolic BP used by nephrologists for patients on PD varied, ranging from < 110 to < 160 mmHg.
conclusionsAlthough clinic BP has served as the primary basis for epidemiologic studies linking BP with adverse outcomes in PD, real-world practice appears to depend heavily on home BP measurements. This reliance occurs despite variable oversight of home BP measurement technique among US nephrologists caring for patients on PD. These findings highlight a disconnect between the evidence base and clinical practice. Prospective studies are needed to determine whether home BP-guided management improves outcomes and to define optimal BP targets in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.